Janus Henderson Group plc 13D and 13G filings for Eagle Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 10:25 am Sale |
2024-09-30 | 13G | Eagle Pharmaceuticals, Inc. EGRX |
JANUS HENDERSON GROUP PLC JHG |
0 0.000% |
-775,525 (Position Closed) |
Filing |
| 2024-02-13 3:53 pm Sale |
2023-12-31 | 13G | Eagle Pharmaceuticals, Inc. EGRX |
JANUS HENDERSON GROUP PLC JHG |
775,525 6.000% |
-454,347 (-36.94%) |
Filing |
| 2023-02-13 09:26 am Sale |
2022-12-31 | 13G | Eagle Pharmaceuticals, Inc. EGRX |
JANUS HENDERSON GROUP PLC JHG |
1,229,872 9.400% |
-298,280 (-19.52%) |
Filing |
| 2022-02-10 6:01 pm Sale |
2021-12-31 | 13G | Eagle Pharmaceuticals, Inc. EGRX |
JANUS HENDERSON GROUP PLC JHG |
1,528,152 11.800% |
-165,921 (-9.79%) |
Filing |
| 2021-02-11 4:39 pm Sale |
2020-12-31 | 13G | Eagle Pharmaceuticals, Inc. EGRX |
JANUS HENDERSON GROUP PLC JHG |
1,694,073 13.000% |
-105,636 (-5.87%) |
Filing |